Cargando...
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes
IMPORTANCE: Results of clinical trials suggest that canagliflozin, a sodium-glucose cotransporter 2 (SGLT-2) inhibitor for treating type 2 diabetes, may be associated with lower extremity amputation. OBJECTIVE: To quantify the association between the use of oral medication for type 2 diabetes and 5...
Guardado en:
| Publicado en: | JAMA Intern Med |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Medical Association
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142968/ https://ncbi.nlm.nih.gov/pubmed/30105373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.3034 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|